Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 1.699% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COc1cc(C)c(Br)cc1S(=O)(=O)NCc1ccccc1
b.) Cc1ccc(C(=O)CN2C(=O)NC3(CCc4ccccc43)C2=O)s1
Answer: b. Cc1ccc(C(=O)CN2C(=O)NC3(CCc4ccccc43)C2=O)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)CN2C(=O)NC3(CCc4ccccc43)C2=O)s1
Cc1ccc(C(=O)CN2C(=O)NC3(CCc4ccccc43)C2=O)s1
3'-[2-(5-methylthiophen-2-yl)-2-oxoethyl]spiro[1,2-dihydroindene-3,5'-imidazolidine]-2',4'-dione